SCHEMBL867129

SCHEMBL867129

O=C(O)COc1ccccc1C(=O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.68
DRD2 P14416 1/20 0.56
DRD1 P21728 1/20 0.56
DRD3 P35462 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
POLB P06746 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GLA P06280 1/20 0.56
ABCB1 P08183 5/20 0.54
KDM4E B2RXH2 2/20 0.53
HTT P42858 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
ELANE P08246 1/20 0.53
AKR1C3 P42330 1/20 0.50
ALOX15 P16050 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29388652 1.00 PTGDR2 (0.68) PTGDR2DRD2DRD1DRD3L3MBTL1
SCHEMBL8414408 0.91 L3MBTL1 (0.61) PTGDR2L3MBTL1POLBSMN1; SMN2GLA
SCHEMBL8414412 0.87 PTGDR2 (0.57) PTGDR2DRD2DRD1DRD3L3MBTL1
SCHEMBL29536167 0.87 PTGDR2 (0.54) PTGDR2DRD2DRD1DRD3L3MBTL1
SCHEMBL22209162 0.86 HTT (0.73) PTGDR2DRD2DRD1DRD3SMN1; SMN2
SCHEMBL30149165 0.84 DRD2 (0.57) PTGDR2DRD2DRD1DRD3ABCB1
SCHEMBL769670 0.84 DRD2 (0.57) PTGDR2DRD2DRD1DRD3ABCB1
SCHEMBL538221 0.83 ELANE (0.51) PTGDR2DRD2DRD1DRD3POLB
SCHEMBL16092725 0.83 MEN1 (0.61) PTGDR2POLBSMN1; SMN2KDM4EHTT
SCHEMBL29502958 0.83 KDM4E (0.73) PTGDR2L3MBTL1POLBSMN1; SMN2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024118440-A1 UV COATINGS FOR MONOWEB FILMS AND LABELS SUN CHEMICAL CORPORATION (US) 2024-06-06 WO claimed
US-11794452-B2 Thermoplastic polymer film with interpenetrating polymer network ARGOTEC LLC 2023-10-24 US claimed
US-20230242774-A1 A PHOTOPOLYMER EPOXY COMPOSITION AND A PHOTOINITIATOR FOR CURING SAME POLYMER GVULOT LTD (IL) 2023-08-03 US claimed
EP-4157916-A1 A PHOTOPOLYMER EPOXY COMPOSITION AND A PHOTOINITIATOR FOR CURING SAME Polymer Gvulot Ltd. (IL) 2023-04-05 EP claimed
EP-3445826-B1 RADIATION CURABLE INK FORMULATION FLINT GROUP GERMANY GMBH (DE) 2021-07-14 EP claimed
EP-3710249-A1 THERMOPLASTIC POLYMER FILM WITH INTERPENETRATING POLYMER NETWORK SWM Luxembourg Sarl (LU) 2020-09-23 EP claimed
EP-2852374-B1 PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE/PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE OREAL (FR) 2019-08-21 EP claimed
US-20190152200-A1 THERMOPLASTIC POLYMER FILM WITH INTERPENETRATING POLYMER NETWORK ARGOTEC LLC 2019-05-23 US claimed
EP-3200754-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2017-08-09 EP claimed
US-20170209360-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2017-07-27 US claimed
WO-2016050793-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES L'OREAL (FR) 2016-04-07 WO claimed
JP-54030141-A None JP disclosed
JP-53082760-A None JP disclosed
EP-4662002-A1 MICROCAPSULES Albotherm Limited (GB) 2025-12-17 EP disclosed
US-20250346721-A1 FOAM COMPOSITION INCLUDING SILICONE MQ RESINS AND RELATED ARTICLES AND PROCESSES 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-11-13 US disclosed
WO-2000037444-A1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2000-06-29 WO disclosed
EP-0934247-A1 PHOTOINITIATORS Lambson Fine Chemicals Limited (GB) 1999-08-11 EP disclosed
WO-1997049664-A1 PHOTOINITIATORS LAMBSON FINE CHEMICALS LIMITED (GB) 1997-12-31 WO disclosed
JP-S5430141-A NOVEL BENZOYLPHENOXYACETIC ACID DERIVATIVES KAKEN PHARMACEUT CO LTD 1979-03-06 JP disclosed
JP-S5382760-A NOVEL BENZOYLPHENOXYACETIC ACID DERIVS., PROCESS FOR THEIR PREPARATION AND LIPID LOWERING AGENTS CONTG. ACTIVE CONSTITUENTS KAKEN PHARMACEUT CO LTD 1978-07-21 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209360-A1 COSMETIC PROCESS FOR ATTENUATING WRINKLES CUTA, MC1R, GLA PTGDR2 3297/4885DRD2 2506/4885DRD1 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.